By MONICA KAYOMBO
AS the world marks World AIDS Day, the Global Fund’s ambitious goal to save 23 million lives and prevent 400 million cases of HIV, TB, and malaria hangs in the balance.
The clock is ticking, and the stakes are high.
With a target of US$18 billion, the Global Fund’s Eighth Replenishment is facing significant headwinds, including macroeconomic challenges and geopolitical tensions.
The latest Lancet publication emphasises that the consequences of failure are dire as millions could lose access to life-saving treatment, and health systems could collapse.
The Global Fund’s investment in combating HIV, TB, and malaria has yielded remarkable results, saving an estimated 70 million lives since 2002. However, the current funding shortfall threatens to reverse these gains.
Despite these challenges, the Global Fund remains committed to its mission. The United States, the largest donor, has pledged $4.6 billion, but more is needed.
Other donors, including the UK, Germany, France, Japan, Sweden, and the European Commission, have also made pledges, but the total falls short of the target.
The global health landscape is shifting, with Gavi, the Vaccine Alliance, and other initiatives taking center stage.
However, the Global Fund’s unique role in combating HIV, TB, and malaria cannot be overstated.
The organisation’s work has provided antiretroviral therapy (ARVs) to 25.6 million people with HIV, treatment for tuberculosis to 7.4 million people, and enabled the distribution of 162 million bed nets to prevent malaria.
The numbers are compelling: every $1 invested returns up to $3.50 in direct economic benefits.
A study by Timothy Hallett and colleagues, including some from the Global Fund, laid out the case for investment in controlling HIV, malaria, and TB.
The returns on investment are clear, and the need is urgent.
As the world grapples with the challenges of global health, Africa is taking the lead.
The Lusaka Agenda, launched in December 2023, calls for sustainable, domestically financed health services and a new era of self-determination. The Africa Health Sovereignty Summit in August saw the launch of the Accra Reset, an agreement that Africa must move from aid dependency to self-determination.
The Accra Reset is not just a call to action; it’s a roadmap for reimagining global health governance. Africa CDC Director General Jean Kaseya describes the self-determination agenda as “an invitation to a new partnership model in which Africa leads with clarity and confidence, and global partners engage as enablers and not directors of continental priorities.”
Sania Nishtar, the head of Gavi, has also written about the need for a new consensus, observing that change is coming, driven at least partly by adverse circumstances.




